School of Medicine
Showing 1-10 of 22 Results
Associate Professor of Medicine (Oncology) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Wakelee's research is focused on clinical trials in patients with lung cancer and other thoracic malignancies such as thymoma and thymic carcinoma. She also works with novel agents for all malignancies as part of the developmental therapeutics group of the cancer center. Other interests include translation projects in thoracic malignancies and collaborations with population scientists regarding lung cancer questions.
Shan X. Wang
Professor of Materials Science and Engineering and of Electrical Engineering and, by courtesy, of Radiology
Current Research and Scholarly Interests Dr. Wang is the Director of Stanford Center for Magnetic Nanotechnology, and the Co-PI of the Stanford Center for Cancer Nanotechnology Excellence. His research interests lie in nanotechnology and information storage, including magnetic/spintronic biochips, in vitro diagnostics, cell sorting, magnetic nanoparticles, nano-patterning, spin electronic materials and sensors, as well as magnetic integrated inductors and transformers.
Klaus Bensch Professor in Experimental Pathology, Emerita
Current Research and Scholarly Interests The main focus of our research is to understand how cells maintain genome integrity by checkpoint mechanisms during chromosome replication.
Professor of Surgery (General Surgery) at the Stanford University Medical Center
Current Research and Scholarly Interests Clinical trials in operative procedures such as Nipple-sparing mastectomy, arm lymphatic mapping, skin perfusion and Treatments for Breast Cancer, especially local recurrence. Dr. Wapnir is institutional Principal Investigator and Chair for National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. Laboratory and translational research includes exploring the activity of breast iodide transporter in breast cancer brain metastasis.
Ronald F. Dorfman, M.B.B.ch., FRCPath, Professor in Hematopathology, Emeritus
Current Research and Scholarly Interests As an Emeritus Professor, I no longer have a research laboratory and devote my half-time effort to lymphoma diagnosis and teaching. I do devote a small amount of effort to lymphoma research in collaboration with Yaso Natkunam and others in the Department of Pathology.
William M. Hume Professor in the School of Medicine, Professor of Structural Biology, of Molecular and Cellular Physiology and of Photon Science
Current Research and Scholarly Interests Our laboratory studies molecular interactions that underlie the establishment and maintenance of cell and tissue structure. Our specific areas of interest are the architecture and dynamics of intercellular adhesion junctions, the molecular basis of cell polarity, and the Wnt signaling pathway. We also have a long-standing interest in carbohydrate-based cellular recognition and adhesion.
Virginia & D.K. Ludwig Professor for Clinical Investigation in Cancer Research, Professor of Developmental Biology &, by courtesy, of Biology
Current Research and Scholarly Interests Stem cell and cancer stem cell biology; development of T and B lymphocytes; cell-surface receptors for oncornaviruses in leukemia. Hematopoietic stem cells; Lymphocyte homing, lymphoma invasiveness and metastasis.
Mark Lane Welton
Harry A. Oberhelman, Jr. Professor
Current Research and Scholarly Interests Clinical research focused on the diagnosis, prevention and treatment of anal cancer and its precursor lesions. Clinical trials of ablative therapy for High-grade Squamous Intraepithelial Lesions (HSIL) of the anus and perianal tissues as a means for preventing anal cancer.
Basic science work in collaboration with Ronald Davis and Hanlee Ji focused on the molecular genetic and pathologic studies of anal cancers using moecular inversion probe genomic technology
Francis W. Bergstrom Professor of Chemistry and Professor, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly Interests Molecular imaging, therapeutics, drug delivery, drug mode of action